Global Corporate Affairs Archives | Page 329 of 1087 | Be Korea-savvy

Archive by category Global Corporate Affairs

KFSH&RC Achieves Remarkable 98% Survival Rate in 400 Robotic Cardiac Surgeries

KFSH&RC Achieves Remarkable 98% Survival Rate in 400 Robotic Cardiac Surgeries

RIYADH, Saudi Arabia, Jul. 4 (Korea Bizwire) — King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of today, 400 robotic cardiac surgeries have been performed with a [...]

Iveco Group Successfully Raises 290 Million Euros through a Schuldschein Loan

Iveco Group Successfully Raises 290 Million Euros through a Schuldschein Loan

Turin, Jul. 4 (Korea Bizwire) – Iveco Group N.V. (EXM: IVG), a global automotive leader active in the Commercial & Specialty Vehicles, Powertrain and related Financial Services arenas, has successfully raised a Schuldschein loan (a private placement governed by German law) for 290 million euros. The loan comprises two tranches with maturities at three and five [...]

aiMotive Achieves ISO 26262 ASIL D Re-certification for aiSim 5

aiMotive Achieves ISO 26262 ASIL D Re-certification for aiSim 5

Pioneering safety in ADAS/AD simulation MOUNTAIN VIEW, Calif., July 04, 2024 (Korea Bizwire) – aiMotive, a global leader in automotive simulation technology, has obtained ISO 26262 certification from TÜV Nord for the latest generation of its simulator, aiSim 5. Originally granted in 2020, aiSim was the world’s first simulator for ADAS/AD to achieve this certification! TÜV [...]

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (Korea Bizwire) – Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. [...]

IVI RMA Global and Lavima Fertility Join Forces in Research in Fertility Treatments

IVI RMA Global and Lavima Fertility Join Forces in Research in Fertility Treatments

VALENCIA, Spain and BRUSSELS, July 03, 2024 (Korea Bizwire) – Seeking alternatives to obtain oocytes without ovarian stimulation is a pioneering line of research in reproductive medicine. The inconveniences that the process of ovarian stimulation can generate are a current barrier for some women and couples who are considering starting a reproductive treatment. In fact, [...]

Cosmic Kittens (CKIT) is Set to Launch a Space-themed Play-to-earn Game Featuring Unique NFTs and an Engaging Meme Gaming Ecosystem

Cosmic Kittens (CKIT) is Set to Launch a Space-themed Play-to-earn Game Featuring Unique NFTs and an Engaging Meme Gaming Ecosystem

DUBAI, United Arab Emirates, July 03, 2024 (Korea Bizwire) – Cosmic Kittens (CKIT) is a new face in blockchain gaming that combines space-themed NFT cats with attractive P2E rewards. Cosmic Kittens (CKIT) is set to make waves in the blockchain gaming sector with its innovative approach, merging space-themed NFT cats with engaging Play-to-Earn (P2E) mechanics. Built [...]

Constellation Brands Reports First Quarter Fiscal 2025 Financial Results

Constellation Brands Reports First Quarter Fiscal 2025 Financial Results

ROCHESTER, N.Y., July 03, 2024 (Korea Bizwire) – Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, reported today its first quarter fiscal 2025 financial results. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer, Bill Newlands, and Chief Financial Officer, Garth Hankinson, on Wednesday, [...]

Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank

Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank

REGULATED INFORMATION INSIDE INFORMATION Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank Mont-Saint-Guibert, Belgium – July 3, 2024, 12:30pm CET / 6:30am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea [...]

Olon Group Announces the Acquisition of GTP Bioways Group

Olon Group Announces the Acquisition of GTP Bioways Group

MILAN, July 03, 2024 (Korea Bizwire) – GTP Bioways Group is a French company operating as Biotech CDMO (Contract Developing and Manufacturing Organisation), specialising in R&D Services, process development and production of mAbs, enzymes, proteins, nanodrugs, ADCs and F&F. GTP Bioways Group, with multiple locations across France, specializes in delivering comprehensive services to biopharmaceutical companies. From [...]